Evecxia Therapeutics
- | Biotech or pharma, therapeutic R&D
Raising $15m for Phase 2 trial in Obsessive-Compulsive Disorder (OCD), arguably the most attractive investment opportunity in Psychiatry — i.e., massive unmet need; risk-mitigated MoA & trials; low competition.
Address
North CarolinaUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}